ClinicalTrials.gov
ClinicalTrials.gov Menu

Treating Acute MI Patients With Aggrastat on Their Way to Hospital

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00300833
Recruitment Status : Unknown
Verified January 2009 by The Baruch Padeh Medical Center, Poriya.
Recruitment status was:  Recruiting
First Posted : March 10, 2006
Last Update Posted : August 11, 2011
Sponsor:
Information provided by:
The Baruch Padeh Medical Center, Poriya

Brief Summary:
Treating an AMI patient with ST elevation with Aggrastat in the ambulance on his or her way to the hospital.

Condition or disease Intervention/treatment Phase
Acute Myocardial Infarction Drug: Tirofiban Phase 4

Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 200 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Study Start Date : January 2006
Estimated Primary Completion Date : January 2012

Resource links provided by the National Library of Medicine

U.S. FDA Resources


Intervention Details:
    Drug: Tirofiban
    pci


Primary Outcome Measures :
  1. mortality [ Time Frame: immidiately ]

Secondary Outcome Measures :
  1. TIMI flow [ Time Frame: 24 hours ]
    feeling better



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

patients with acute Myocardial infarction with ST elevation , and moving by ambulance to Poriya hospital

Exclusion Criteria:

  • women less than 50 years old and 80 years old, bleeding tendency, stroke in the past

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00300833


Contacts
Contact: Yonathan Hasin, Professor 97246652648 yhasin@poria.health.gov.il

Locations
Israel
Cardiovascular Division, The Baruch Padeh Medical Center, Poriya, Recruiting
Tiberias, Israel, 15208
Magen David , Recruiting
Tiberias, Israel
Contact: Sergay Krablikov, Dr         
Sponsors and Collaborators
The Baruch Padeh Medical Center, Poriya
Investigators
Study Chair: Menachem Naheer The Baruch Padeh Medicel Center, Poriya, Tiberias, Israel

Responsible Party: Menachem Nahir, The baruch Padeh Medical center
ClinicalTrials.gov Identifier: NCT00300833     History of Changes
Other Study ID Numbers: Aggrastat in AMI.CTIL
First Posted: March 10, 2006    Key Record Dates
Last Update Posted: August 11, 2011
Last Verified: January 2009

Additional relevant MeSH terms:
Infarction
Myocardial Infarction
Ischemia
Pathologic Processes
Necrosis
Myocardial Ischemia
Heart Diseases
Cardiovascular Diseases
Vascular Diseases
Tirofiban
Fibrinolytic Agents
Fibrin Modulating Agents
Molecular Mechanisms of Pharmacological Action
Platelet Aggregation Inhibitors